1-Invitation letter – Meeting Agenda – Power of Attorney
2 -Report of the Board of Directors
3-Statement to pass audited financial statements 2022
4-Report of the Board of Management
5-Report of the Supervisory Board
6-Report of Independent Auditors
7-Report on operating expenses of the BOD and the SB
8 -Statement on operating expenses of the BOD 2023
9-Statement on Profit distribution of 2022 and dividend payment plan of 2023
10-Proposal to issue more shares to increase the Charter Capital
11-Report on selection of an independent auditing firm
12-Report on changing the Company’s management structure
13. Proposal on amendments and supplementation to the Charter
14. Proposal on amendments and supplementation to the internal regulation on governance
15-Proposal on amendments and supplementation to the operational regulation of the Board of Directors
16-Draft Resolution of the General Meeting of Shareholders 2023
17-Voting Card
18-On the number of members and the nomination and self-nomination list for membership of the Board of Directors of Imexpharm Corporation, term 2023-2027